↑↓ navigate open esc close
Germany TED / Vergabe.de contract award · ocds-ted-495360-2025-1

Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum W

DAK-Gesundheit awarded a contract of undisclosed value to 1 A Pharma GmbH for Healthcare & Medical in July 2025 — one of 389 awards this buyer has made.

29 Jul 2025
Award date
Not disclosed
Contract value

Buying agency

DAK-Gesundheit
389 Awards
€581K Avg award

Winning supplier

1 A Pharma GmbH
18 Awards
5 Buyers
€668K Total won

Contract description

Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Azelastin + Fluticason, ATC R01AD28 für die Zeit 01.02.2024 - 31.01.2026

Premium

Related awards · DAK-Gesundheit

389 awards

The buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.

Tender no.SupplierAmountDateSector

Full dataset

Unlock the full data.

Subscribe to reveal every row, year-over-year trends, and CSV / API export.

Unlock full dataset →

345 more awards from this buyer · full history & CSV export

Premium

Other wins · 1 A Pharma GmbH

18 wins

The supplier's complete win history across every buyer it sells to — not just the handful shown here.

Premium · full dataset

See the full award context.

Competing bids, award margins and every related contract for DAK-Gesundheit and 1 A Pharma GmbH — one subscription unlocks everything.

Sign Up Free →

Free account · cancel anytime · 14-day money-back

Sign Up